GUELPH, ON, Jan. 2, 2013 /CNW/ - BIOREM Inc. (TSX-V: BRM) ("Biorem" or
"the Company") is pleased to announce the recent receipt of four new
orders totalling $2.2 million.
The largest order, exceeding $1.4 million, is for an industrial VOC
(Volatile Organic Compound) and odour removal project in Moscow,
Russia, which is the 5th order from this large European multinational client. Biorem has
utilized its BiosorbensR proprietary biofilter media technology in the design of the five
projects which is highly effective for this particular VOC emission.
Biorem was also awarded its 3rd order from a major petrochemical client in Brazil for a system to
destroy odour and VOC emissions from a refinery waste water treatment
Two additional orders for odour control systems within municipal waste
water treatment plants in Canada and USA were also received. Each of
the 4 orders are scheduled for completion in 2013.
"Biorem has been methodically developing biological treatment processes
through its advanced research and development activities for several
years to commercialize solutions for VOC air abatement systems" said
Peter Bruijns, President & CEO. "Our commercial approach is to proceed
steadily and systematically into target market niches within this vast
$2.5 billion global market by ensuring reliable VOC abatement systems
are provided to our customers."
About BIOREM Inc.
Biorem is a leading clean technology company that designs, manufactures
and distributes a comprehensive line of high-efficiency air emissions
control systems used to eliminate odors, volatile organic compounds
(VOCs), and hazardous air pollutants (HAPs). With sales and
manufacturing offices across the continent, a dedicated research
facility, a worldwide sales representative network and more than 700
installed systems worldwide, Biorem offers state-of-the-art
technology-based products and peace of mind for municipalities,
industrial companies and their surrounding communities. Additional
information on Biorem is available on our website at www.biorem.biz.
SOURCE: Biorem Inc.